Pharmaceuticals, Biotechnology and Life Sciences
Valneva SE, a specialty vaccine company, said on Friday that the Committee for Medicinal Products for Human Use (CHMP) of…
REDWOOD CITY, Calif., March 01, 2025 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company…
– Greatly improved patient quality of life and reduced disease impact in patients with CSU and CIndU — 82% of…
LEXINGTON, Mass., Feb. 28, 2025 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on…
Presented positive interim data through 52 weeks and beyond for 4D-150 in wet AMD from PRISM Phase 1/2 clinical trial…
SAN MATEO, Calif., Feb. 28, 2025 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that the previously signed…
Cenerimod is a novel oral S1P1 receptor modulator with potential to be a first- or best-in-class therapy for multiple autoimmune…
Financial Results and Operational Update for Half-Year Ended December 31, 2024NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited…
Issues Full Year 2025 Financial GuidanceRADNOR, Pa., Feb. 26, 2025 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader…
Full Year 2024 Total Revenues of $491.7 Million, Marking Another Year of Record Growth Full Year 2024 Total Revenues Grew…